These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12840547)

  • 1. Detection of aggregates and protein inclusions by staining of tissues.
    Galvin JE
    Methods Mol Biol; 2003; 232():149-64. PubMed ID: 12840547
    [No Abstract]   [Full Text] [Related]  

  • 2. Primary progressive aphasia as the initial manifestation of corticobasal degeneration and unusual tauopathies.
    Ferrer I; Hernández I; Boada M; Llorente A; Rey MJ; Cardozo A; Ezquerra M; Puig B
    Acta Neuropathol; 2003 Nov; 106(5):419-35. PubMed ID: 12955398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Following the leader: fibrillization of alpha-synuclein and tau.
    Frasier M; Wolozin B
    Exp Neurol; 2004 Jun; 187(2):235-9. PubMed ID: 15144849
    [No Abstract]   [Full Text] [Related]  

  • 4. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies.
    Chalmers KA; Love S
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1019-26. PubMed ID: 17984683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of "aggregation-prone" and "aggregation-susceptible" regions in proteins associated with neurodegenerative diseases.
    Pawar AP; Dubay KF; Zurdo J; Chiti F; Vendruscolo M; Dobson CM
    J Mol Biol; 2005 Jul; 350(2):379-92. PubMed ID: 15925383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lewy bodies in the amygdala: increase of alpha-synuclein aggregates in neurodegenerative diseases with tau-based inclusions.
    Popescu A; Lippa CF; Lee VM; Trojanowski JQ
    Arch Neurol; 2004 Dec; 61(12):1915-9. PubMed ID: 15596612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tauists, Baptists, Syners, Apostates, and new data.
    Trojanowski JQ
    Ann Neurol; 2002 Sep; 52(3):263-5. PubMed ID: 12205637
    [No Abstract]   [Full Text] [Related]  

  • 8. What determines the molecular composition of abnormal protein aggregates in neurodegenerative disease?
    Armstrong RA; Lantos PL; Cairns NJ
    Neuropathology; 2008 Aug; 28(4):351-65. PubMed ID: 18433435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain tissue microarrays in neurodegenerative diseases: validation of methodology and immunohistochemical study of growth-associated protein-43 and calretinin.
    Takei H; Buckleair LW; Rivera A; Powell SZ
    Pathol Int; 2007 Dec; 57(12):775-83. PubMed ID: 17988278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variability and heterogeneity in Alzheimer's disease with cotton wool plaques: a clinicopathological study of four autopsy cases.
    Yokota O; Terada S; Ishizu H; Ujike H; Ishihara T; Namba M; Hayashi Y; Nishinaka T; Namba R; Nakashima H; Uéda K; Checler F; Kuroda S
    Acta Neuropathol; 2003 Oct; 106(4):348-56. PubMed ID: 12883830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exon 3 insert of tau protein in neurodegenerative diseases.
    Terada S; Ishizu H; Ishiguro K; Tanabe Y; Itoh N; Yasutake K; Furubayashi A; Kitamura Y; Kuroda S
    Acta Neuropathol; 2005 Jul; 110(1):12-8. PubMed ID: 15918074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Environmental reduplicative paramnesia in a case of atypical Alzheimer's disease.
    von Gunten A; Miklossy J; Suvà ML; Hof PR; Giannakopoulos P
    J Neurol; 2004 Jun; 251(6):750-2. PubMed ID: 15311354
    [No Abstract]   [Full Text] [Related]  

  • 13. Protein aggregates and dementia: is there a common toxicity?
    Lovestone S; McLoughlin DM
    J Neurol Neurosurg Psychiatry; 2002 Feb; 72(2):152-61. PubMed ID: 11796764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiazin red as a neuropathological tool for the rapid diagnosis of Alzheimer's disease in tissue imprints.
    Luna-Muñoz J; Peralta-Ramirez J; Chávez-Macías L; Harrington CR; Wischik CM; Mena R
    Acta Neuropathol; 2008 Nov; 116(5):507-15. PubMed ID: 18810470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alzheimer disease pathology in amyotrophic lateral sclerosis.
    Hamilton RL; Bowser R
    Acta Neuropathol; 2004 Jun; 107(6):515-22. PubMed ID: 15024584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brainstem pathology in DYT1 primary torsion dystonia.
    McNaught KS; Kapustin A; Jackson T; Jengelley TA; Jnobaptiste R; Shashidharan P; Perl DP; Pasik P; Olanow CW
    Ann Neurol; 2004 Oct; 56(4):540-7. PubMed ID: 15455404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Conformationally altered proteins cause neurodegenerative diseases].
    Ingelsson M; Nilsson L; Basun H; Aquilonius SM; Lannfelt L
    Lakartidningen; 2005 Nov 21-27; 102(47):3542-3, 3545-6, 3549 passim. PubMed ID: 16408392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alpha-synuclein aggregation and its relation to neurodegenerative diseases.
    Papapetropoulos S; Mash DC
    Ann Neurol; 2005 Apr; 57(4):605; author reply 605-6. PubMed ID: 15786478
    [No Abstract]   [Full Text] [Related]  

  • 19. Pathways to primary neurodegenerative disease.
    Hardy J
    Neurologia; 2002 Oct; 17(8):399-401. PubMed ID: 12396967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High cholesterol content in neurons increases BACE, beta-amyloid, and phosphorylated tau levels in rabbit hippocampus.
    Ghribi O; Larsen B; Schrag M; Herman MM
    Exp Neurol; 2006 Aug; 200(2):460-7. PubMed ID: 16696972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.